Previous 10 |
home / stock / gnftf / gnftf news
Editor's note: Seeking Alpha is proud to welcome First Genesis Consulting as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Pro. Click here to find out more » A healt...
We are kicking off our "Theme of the Month" series today, covering a themed topic for every month. For February, it's NASH (non-alcoholic steatohepatitis). In other months, we will take up diseases, conferences, or anything else that needs deep focus. For more details about the NASH schedule, ...
In a recent note , we briefly discussed the two leading players in the NASH space: Genfit ( GNFTF ) and Intercept ( ICPT ). The note though did not dig deep into the science behind the two drug candidates, Genfit’s elafibranor and Intercept’s OCA. In this article, we will be foc...
After Gilead 9;s ( GILD ) Hepatitis-C franchise met with phenomenal success and equally phenomenal decline, focus shifted to a new area in the liver space; non-alcoholic steatohepatitis or NASH as it is more commonly known now. NASH is the next stage of non-alcoholic fatty liver disease o...
News, Short Squeeze, Breakout and More Instantly...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the positiv...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 - GENFIT (Nasdaq and Euronext: GNFT) , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the inclusi...
Ipsen’s Iqirvo ® (elafibranor) 80 mg tablets receives U.S. FDA accelerated approval as a first-in-class treatment for Primary Biliary Cholangitis (PBC) First-ever drug developed in-house by GENFIT to achieve U.S. FDA’s approval GENFIT is eligible to ...